Non-muscle-invasive bladder cancer represents 75% of primary diagnoses and is characterized by frequent recurrence but a low risk of mortality. In this Timeline article, Mertens and colleagues discuss landmark events in the detection, diagnosis, and treatment of non-muscle-invasive bladder cancer.
- Laura S. Mertens
- Yann Neuzillet
- Bas W. G. van Rhijn